About
Biovance Capital is a new € 51M fund to invest in early-stage biotech companies across Europe developing innovative therapeutics in all disease areas and drug modalities (small and large molecules, vaccines, cell, and gene therapies).
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 289 investors are based in Lisbon, Lisboa, Portugal.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Lisbon, Portugal
Contact Information
linkedin.com/in/••••••••
Find more investors like Biovance
Search Investors